eclitasertib (DNL758) / Harvard University, Sanofi, Denali Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eclitasertib (DNL758) / Denali Therap, Sanofi
NCT04469621: A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Completed
1b
68
RoW
SAR443122, Placebo
Sanofi
Corona Virus Infection
10/20
10/20

Download Options